Skip to main content
ORTIN GLOBAL LIMITED logo

ORTIN GLOBAL LIMITED — Investor Relations & Filings

Ticker · ORTINGLOBE ISIN · INE749B01020 BSE.NS Manufacturing
Open in API
Filings indexed 204 across all filing types
Latest filing 2024-02-06 Regulatory Filings
Country IN India
Listing BSE.NS ORTINGLOBE

About ORTIN GLOBAL LIMITED

https://www.ortinlabsindia.com/

Ortin Global Limited is a pharmaceutical enterprise engaged in the development, manufacture, and marketing of active pharmaceutical ingredients (APIs), intermediates, and finished dosage formulations. The company maintains a diverse product portfolio covering various therapeutic segments, such as anti-diabetics, anti-hypertensives, anti-retrovirals, analgesics, and anti-pyretics. Its operations include the synthesis of complex chemical molecules and the production of oral solids and liquids, including tablets, capsules, and syrups. With a focus on integrated manufacturing processes, the company serves both domestic and international healthcare markets. Ortin Global Limited prioritizes research and development to expand its product offerings and optimize production techniques, ensuring compliance with established quality standards across its manufacturing facilities.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text is extremely short (114 characters) and contains only a digital signature with a date. There is no substantive content, financial data, or report information. It does not contain any report, announcement, or detailed information. This fits the criteria for a Regulatory Filing (RNS) as a fallback category for minimal or miscellaneous filings without report content.
2024-02-06 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2024-01-18 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (112 characters) and contains only a digital signature with a date and time stamp. There is no substantive content, financial data, or report information. It does not contain any report, announcement, or detailed information. According to the rules, such a document is best classified as a Regulatory Filing (RNS) since it does not fit any other category and appears to be a certification or attestation type of filing.
2023-12-29 English
Shareholders meeting
Regulatory Filings
2023-12-14 English
Copy of Newspaper Publication
Regulatory Filings
2023-12-05 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of an Extraordinary General Meeting (EGM) for the fiscal year 2023-24 of Ortin Laboratories Limited. It includes details about the special business to be transacted, specifically the approval for the sale/disposal of company property. The document references the Companies Act, 2013, SEBI regulations, and provides explanatory statements and notes related to the EGM. It is not a full report but a notice calling for shareholder approval on a specific resolution. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), as it is a material sent to shareholders to provide information and request votes for the meeting.
2023-11-22 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.